These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 27799249)

  • 41. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
    Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
    Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3.
    Han X; Shi H; Sun Y; Shang C; Luan T; Wang D; Ba X; Zeng X
    Cell Death Dis; 2019 Aug; 10(8):598. PubMed ID: 31395859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways.
    Cui D; Zhao Y; Xu J
    Cancer Biol Ther; 2019; 20(5):608-616. PubMed ID: 30404567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.
    Barrera L; Montes-Servín E; Hernandez-Martinez JM; Orozco-Morales M; Montes-Servín E; Michel-Tello D; Morales-Flores RA; Flores-Estrada D; Arrieta O
    Cancer Immunol Immunother; 2018 Sep; 67(9):1393-1406. PubMed ID: 29974189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma.
    Mestas J; Burdick MD; Reckamp K; Pantuck A; Figlin RA; Strieter RM
    J Immunol; 2005 Oct; 175(8):5351-7. PubMed ID: 16210641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
    Karin N
    Front Immunol; 2020; 11():557586. PubMed ID: 33193327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
    Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
    J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.
    Horikawa N; Abiko K; Matsumura N; Hamanishi J; Baba T; Yamaguchi K; Yoshioka Y; Koshiyama M; Konishi I
    Clin Cancer Res; 2017 Jan; 23(2):587-599. PubMed ID: 27401249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes.
    Neamah WH; Singh NP; Alghetaa H; Abdulla OA; Chatterjee S; Busbee PB; Nagarkatti M; Nagarkatti P
    J Immunol; 2019 Oct; 203(7):1830-1844. PubMed ID: 31492743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.
    Sheng IY; Diaz-Montero CM; Rayman P; Wei W; Finke JH; Kim JS; Pavicic PG; Lamenza M; Company D; Stephenson A; Campbell S; Haber G; Lee B; Mian O; Gilligan TD; Rini BI; Garcia JA; Grivas P; Ornstein MC
    Target Oncol; 2020 Apr; 15(2):211-220. PubMed ID: 32207064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
    Gao W; Zhang X; Yang W; Dou D; Zhang H; Tang Y; Zhong W; Meng J; Bai Y; Liu Y; Yang L; Chen S; Liu H; Yang C; Sun T
    J Immunother Cancer; 2019 Aug; 7(1):231. PubMed ID: 31462297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. METTL3 Inhibits Antitumor Immunity by Targeting m
    Chen H; Pan Y; Zhou Q; Liang C; Wong CC; Zhou Y; Huang D; Liu W; Zhai J; Gou H; Su H; Zhang X; Xu H; Wang Y; Kang W; Kei Wu WK; Yu J
    Gastroenterology; 2022 Oct; 163(4):891-907. PubMed ID: 35700773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma.
    Yokota S; Yonezawa T; Momoi Y; Maeda S
    Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.
    Brandau S; Trellakis S; Bruderek K; Schmaltz D; Steller G; Elian M; Suttmann H; Schenck M; Welling J; Zabel P; Lang S
    J Leukoc Biol; 2011 Feb; 89(2):311-7. PubMed ID: 21106641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer.
    Dominguez C; McCampbell KK; David JM; Palena C
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.
    Bryant AJ; Mehrad B; Brusko TM; West JD; Moldawer LL
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.
    Taki M; Abiko K; Baba T; Hamanishi J; Yamaguchi K; Murakami R; Yamanoi K; Horikawa N; Hosoe Y; Nakamura E; Sugiyama A; Mandai M; Konishi I; Matsumura N
    Nat Commun; 2018 Apr; 9(1):1685. PubMed ID: 29703902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.
    Zhang W; Wang H; Sun M; Deng X; Wu X; Ma Y; Li M; Shuoa SM; You Q; Miao L
    Cancer Commun (Lond); 2020 Mar; 40(2-3):69-80. PubMed ID: 32237072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.